Hot Features
プレミアム
Repare Therapeutics Inc (RPTX)
NASDAQ
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. 詳細を表示
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...
On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December 2024, with the plan to begin a registrational...
Data presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s Phase 1...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported data highlighting the clinical benefits of camonsertib, a...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.18 | -5.53846153846 | 3.25 | 3.25 | 2.75 | 207755 | 2.95185517 | CS |
| 4 | -0.31 | -9.17159763314 | 3.38 | 4.05 | 2.75 | 113144 | 3.26399204 | CS |
| 12 | 0.04 | 1.3201320132 | 3.03 | 4.05 | 2.71 | 113419 | 3.32044412 | CS |
| 26 | -0.34 | -9.9706744868 | 3.41 | 4.29 | 2.71 | 127211 | 3.42927276 | CS |
| 52 | -1.75 | -36.3070539419 | 4.82 | 8.49 | 2.71 | 172904 | 4.63577916 | CS |
| 156 | -23.45 | -88.4238310709 | 26.52 | 27.66 | 2.71 | 228499 | 10.22556387 | CS |
| 260 | -28.98 | -90.4212168487 | 32.05 | 46.44 | 2.71 | 203634 | 15.00298327 | CS |
Monksdream
3月前
Monksdream
7月前
Monksdream
1年前
Gator44
2年前
ElusTrade
2年前
akamaii
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
retireat40
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
ElusTrade
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
Laszlo1
2年前
Just-Keep-Trying
2年前
Just-Keep-Trying
2年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
